Celanese Corp: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Feb 24, 2026 and accepted by EDGAR at Feb 24, 2026, 21:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $9.54bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $7.59bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $1.95bn | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $125.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $899.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$786.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $701.0m | us-gaap:InterestExpense |
| Income tax | 12 months2025-01-01 to 2025-12-31 | −$90.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$1.17bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$10.64 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$10.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 109,530,303 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $1.15bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $343.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $13.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Current assets | At period end2025-12-31 | $5.69bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $21.70bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $3.68bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2025-12-31 | $12.61bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-12-31 | $1.20bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $4.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-26-000031. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.